Edgewise Therapeutics, Inc. Shares Outstanding (Cover Page)
Edgewise Therapeutics, Inc. (EWTX) had Shares Outstanding (Cover Page) of 108.60 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 108.60M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 107.59M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 107.27M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 105.87M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 108.60M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 107.59M shares 10-Q · filed 2026-05-07 |
| 2026-02-19 | 107.27M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 105.87M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 105.35M shares 10-Q · filed 2025-08-07 |
| 2025-04-30 | 105.20M shares 10-Q · filed 2025-05-08 |
| 2025-02-24 | 95.21M shares 10-K · filed 2025-03-03 |
| 2024-10-31 | 94.69M shares 10-Q · filed 2024-11-07 |
| 2024-07-31 | 93.77M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 93.40M shares 10-Q · filed 2024-05-09 |
| 2024-01-31 | 93.11M shares 10-K · filed 2024-02-22 |
| 2023-10-31 | 63.46M shares 10-Q · filed 2023-11-09 |
| 2023-07-31 | 63.46M shares 10-Q · filed 2023-08-10 |
| 2023-04-30 | 63.28M shares 10-Q · filed 2023-05-11 |
| 2023-01-31 | 63.26M shares 10-K · filed 2023-02-23 |
| 2022-10-31 | 63.21M shares 10-Q · filed 2022-11-03 |
| 2022-07-31 | 49.80M shares 10-Q · filed 2022-08-04 |
| 2022-04-30 | 49.58M shares 10-Q · filed 2022-05-11 |
| 2022-01-31 | 49.51M shares 10-K · filed 2022-02-24 |
| 2021-10-31 | 49.30M shares 10-Q · filed 2021-11-10 |
| 2021-07-30 | 49.26M shares 10-Q · filed 2021-08-09 |
| 2021-04-30 | 49.25M shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |